RNF213 and breast cancer: However, ERBB2 amplification was often observed as arm-level events or separate from pter-located GISTIC peaks, including ASPSCR1 and RNF213 (Supplementary Fig. 5B), which is in stark contrast to the minimal amplification of ERBB2 observed in human breast cancers (Supplementary Fig. 5B, inlet).